Follow Us

 FacebookIcon.jpg  TwitterIcon.jpg  YouTubeIcon.jpg  InstagramIcon.jpg

Clinical Trials

Cancer - Breast Cancer

Title
EMBRACA. BRCA Mutant Advanced or Metastatic Breast Cancer
GO29505. Neoadjuvant Treatment for Early Stage Triple Negative Breast Cancer
MONARCH 1. For previously treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
NALA-PUMA 301. HER2 Positive Metastatic Breast Cancer for Patients Who Have Received Two or More Prior HER2 Directed Regimens
Stomatitis Prophylaxis Study for Stage IV, Breast Cancer Patients Receiving Everolimus
TRIO B-09. HER-2 Positive Breast Cancer With CNS Metastasis

Cancer - Colorectal Cancer

Title
INCB 18424-267. Metastatic Colorectal Cancer

Cancer - Heme Malignancies

Title
BIO-001 Heme Malignancies Serum Collection
UTX-IB-104. Ublituximab + Ibrutinib in Select B-cell Malignancies

Cancer - Hodgkin Lymphoma

Title
C25003 Frontline Treatment Trial for Patients With Advanced Classical Hodgkin Lymphoma

Cancer - Lung Cancer

Title
TIGER-1. First line treatment for EGFR Mutant Advanced Non Small Cell Lung Cancer

Cancer - Melanoma

Title
BRIM8: A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma

Cancer - Multiple Myeloma

Title
Amgen 0482. Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma

Cancer - Non-Hodgkin Lymphoma

Title
Yosemite. Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Cancer - Prostate Cancer

Title
JNJ-56021927. Metastatic Castration Resistant Prostate Cancer

Cancer - Breast Cancer

Title
C31001. Advanced or Metastatic Breast Cancer, ER Positive, Her2 Negative

Cancer - GE & Stomach Cancer

Title
GE & Stomach Cancer - MM-111-13-02-04/Merrimack

Cancer - Lung Cancer

Title
NSCLC diagnosis assay development

Cancer - Breast Cancer

Title
Amgen D-Care. Denosumab for Early Stage Breast Cancer
Belle II-Novartis Her2 Negative, metastatic breast cancer
Eisai-208. Her2 Positive Metastatic Breast Cancer

Cancer - Lung Cancer

Title
ARCHER 1042: NSCLC (Stage IIIB/IV) 2nd Line
CA209-153. Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer - Multiple Myeloma

Title
Champion 2012-002. Multiple Myeloma Relapsing or progressive disease.

Cancer - Non-Hodgkin Lymphoma

Title
Bridalveil. Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
C05013. First line treatment DLBC Lymphoma

Cancer - Prostate Cancer

Title
NRX194204 Castration and Taxane resistant Prostate Cancer